The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Rheumatology Champions Call for Lower Prescription Drug Costs, and More in Meeting with Congressional Legislators

Rheumatology Champions Call for Lower Prescription Drug Costs, and More in Meeting with Congressional Legislators

October 16, 2017 • By From the College

  • Tweet
  • Email
Print-Friendly Version / Save PDF

ACR advocates recently returned to Capitol Hill to meet with members of Congress as part of the Advocates for Arthritis fly-in conference on Sept. 26. This annual event brings together rheumatology professionals to advocate on behalf of the rheumatology community. Core issues on which the advocates focused this year include lowering the out-of-pocket cost of prescription drugs, the repeal of arbitrary Medicare therapy caps and to shed light on the role of pharmacy benefit managers in drug pricing.

You Might Also Like
  • Help the ACR Bring Its Message to the Hill
  • Rheumatology Advocates Visit D.C. to Act for Arthritis
  • Eli Lilly Backs U.S. Proposal on Drug Rebates to Lower Costs
Explore This Issue
October 2017
Also By This Author
  • The ACR Gears Up for Rheumatic Disease Awareness Month in September

Help Strengthen the ACR’s Voice in Washington, D.C.

It will take the voice of all rheumatology professionals and patients to get Congress to act. Write, call or email your legislators. As a constituent, your members of Congress are elected to represent you. Ask them to support these priorities:

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Reduce Patients’ Out-of-Pocket Expenses

  • House: Cosponsor H.R. 2999, the Patients’ Access to Treatments Act, to limit patients’ cost-sharing requirements for specialty tier drugs and increase access to lifesaving biologics.
  • Senate: Introduce the Patients’ Access to Treatment Act (PATA) in the Senate; Request a Senate hearing on the use of specialty-tier drug pricing.

Repeal Medicare Therapy Caps

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE
  • House: Cosponsor H.R. 807, the Medicare Access to Rehabilitation Services Act, legislation that would repeal the cap on outpatient rehabilitation services.
  • Senate: Cosponsor S. 253, the Medicare Access to Rehabilitation Services Act.

Expose Pharmacy Benefit Managers’ Role in Prescription Drug Pricing

  • PBMs can drive up drug costs by creating market pressure for higher list prices (the higher the list price, the higher the rebate).
  • PBMs use their position to negotiate contracts with manufacturers, insurers and pharmacies that maximize their profits, often at the expense of patients.
  • PBMs use spread pricing in which they charge an insurer a different amount for given drugs than what it reimburses the pharmacy for dispensing the drugs. This may be kept as extra profit by the PBM.
  • PBMs use drug-switching practices, which increase profits by steering patients toward expensive medications whose manufacturers pay rebates to PBMs for promoting a particular drug.

Be an Effective Advocate When Members of Congress Are at Home

  • Invite your legislators to your office. This is a great opportunity to educate members of Congress on the importance of the rheumatology subspecialty and the effect that arthritis and rheumatic conditions have on quality of life.
  • Meet with your legislators in their district office. An in-person meeting is an effective way to convey your message and allows you to build relationships with your legislators.
  • Volunteer for a campaign. Volunteering is a great way to get involved in the political process. Support the candidate who will best represent the rheumatology community.

We must stay united to effect change. Contact your elected officials and make your voice heard. To find your legislators’ contact information or for more information on ACR advocacy activities, contact advocacy@rheumatology.org, or visit www.rheumatology.org/advocacy.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 | Single Page

Filed Under: From the College, Legislation & Advocacy Tagged With: Advocacy, Advocates for Arthritis, Capitol Hill, Congress, Healthcare, lawmakers, legislators, Medicaid, Medicare, prescription drug costs, reform, Rheumatic Disease, rheumatologyIssue: October 2017

You Might Also Like:
  • Help the ACR Bring Its Message to the Hill
  • Rheumatology Advocates Visit D.C. to Act for Arthritis
  • Eli Lilly Backs U.S. Proposal on Drug Rebates to Lower Costs
  • ACR Aims to Keep Rheumatology on Congressional Radar in 2014

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.